A surprisingly wide range of standard and specialized blood tests can point toward digestive problems, from a routine complete blood count that reveals unexplained anemia to highly specific antibody panels that distinguish one form of inflammatory bowel disease from another. No single blood draw diagnoses most gut conditions on its own, but the patterns these tests create often tell a clinician exactly where to look next. Understanding which tests matter and what they actually measure can help you make sense of your lab results and have more productive conversations with your doctor.
Routine Blood Work That Raises a Red Flag
The first clue to a digestive problem often shows up on blood work ordered for something else entirely. A complete blood count can reveal low hemoglobin and small red blood cells, the hallmarks of iron deficiency anemia. Iron deficiency is tied to a range of gastrointestinal conditions because chronic bleeding, poor absorption, and gut inflammation can all drain iron stores over time.1PubMed Central. Anemia and iron deficiency in gastrointestinal and liver conditions When a doctor sees unexplained iron deficiency, the digestive tract is one of the first places they investigate.
C-reactive protein, or CRP, is another routine marker that can signal gut trouble. CRP rises when there is inflammation anywhere in the body, so it is not specific to the digestive system. But when combined with symptoms like chronic diarrhea or abdominal pain, an elevated CRP helps a clinician separate inflammatory bowel disease from irritable bowel syndrome. One study comparing several diagnostic approaches found that CRP had about 73% overall accuracy for distinguishing IBD from IBS, which is modest but still useful as an early screening step.2PubMed. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies White blood cell counts can also climb with gut inflammation, though their accuracy in that same comparison was only about 63%.
Eosinophils, a specific type of white blood cell counted on a standard CBC, deserve a mention. Elevated eosinophil counts can occur in conditions like eosinophilic esophagitis or parasitic infections of the gut. Research has also explored links between eosinophil levels and the severity of inflammatory bowel disease, though eosinophils appear to play a limited role in bacterial gut infections specifically.3PubMed Central. Eosinophils in infection and intestinal immunity
Liver and Biliary Enzymes
Your liver is part of the digestive system, and a standard liver panel is one of the most informative blood tests for digestive problems. The key enzymes include ALT and AST (markers of liver cell injury), alkaline phosphatase and GGT (markers more closely tied to bile flow), and bilirubin (a waste product processed by the liver). The pattern of which enzymes are elevated matters as much as whether they are elevated at all. When ALT and AST are disproportionately high, that points toward liver cell damage. When alkaline phosphatase and GGT are the dominant elevations, the pattern suggests a problem with bile flow, known as cholestasis.4PubMed. Diagnostic considerations for cholestatic liver disease
Gallstones are a common example of how these patterns play out. Roughly 30% of patients with acute gallbladder inflammation have abnormal alkaline phosphatase or bilirubin, and about half have abnormal aminotransferase levels. But when a gallstone actually blocks the common bile duct, those numbers jump dramatically: around 77% show abnormal alkaline phosphatase, 60% have elevated bilirubin, and 90% have abnormal aminotransferases.5PubMed. Liver test patterns in patients with acute calculous cholecystitis and/or choledocholithiasis A case report framework has described how gallstone-related liver injury typically shows a hepatocellular pattern (ALT and AST dominate), while bile duct obstruction shows a cholestatic pattern (alkaline phosphatase and GGT dominate).6PubMed Central. Gallstone Hepatitis Caused by Transient Common Bile Duct Obstruction in a Middle-Aged Woman So the same set of liver tests can point toward very different problems depending on which enzymes are out of range.
Pancreatic Enzymes
Lipase and amylase are the two blood tests most associated with pancreatic disease. Both enzymes are produced by the pancreas and spill into the bloodstream when pancreatic tissue is injured. In acute pancreatitis, lipase is now the preferred test because it is more sensitive and stays elevated longer than amylase, giving doctors a wider window to catch the diagnosis.7PubMed. Lipase or amylase for the diagnosis of acute pancreatitis? A threshold of two to four times the upper limit of normal is generally used to support the diagnosis, alongside abdominal pain and imaging findings.8PubMed Central. Blood tests for acute pancreatitis
Ordering both lipase and amylase together adds little diagnostic value, so many hospitals have moved to lipase alone to reduce unnecessary lab costs.7PubMed. Lipase or amylase for the diagnosis of acute pancreatitis? One important caveat: neither enzyme predicts how severe a bout of pancreatitis will be. A sky-high lipase does not necessarily mean a worse outcome than a moderately elevated one.
Interestingly, these same enzymes can also point in the opposite direction. In chronic pancreatitis, the pancreas gradually loses its ability to produce enzymes, so amylase and lipase levels can actually fall below normal. Research has identified low cutoff values for amylase and lipase that help identify chronic pancreatitis, though the sensitivity of this approach is limited.9PubMed Central. Low Serum Pancreatic Amylase and Lipase Values Are Simple and Useful Predictors to Diagnose Chronic Pancreatitis
Celiac Disease Antibodies
Celiac disease is one of the digestive conditions where blood testing performs best. The two main antibody tests are tissue transglutaminase (tTG) antibodies and endomysial antibodies (EMA), both of the IgA class. A systematic review found that tTG tests using human recombinant antigen had sensitivities between 91% and 97% and specificities between 96% and 100%, outperforming older gliadin antibody tests.10Clinical Chemistry. Diagnostic Accuracy of Ten Second-Generation (Human) Tissue Transglutaminase Antibody Assays in Celiac Disease EMA tests have near-perfect specificity, meaning a positive result makes celiac disease very likely.11PubMed. The diagnostic accuracy of serologic tests for celiac disease: a systematic review
A more recent meta-analysis found slightly different numbers, with tTG sensitivity around 91% and specificity around 87% in adults, and EMA showing 88% sensitivity with nearly 100% specificity in adults.12PubMed Central. Systematic review with meta-analysis: the accuracy of serological tests to support the diagnosis of coeliac disease The small variations between studies reflect real differences in test kits, patient populations, and how the reference standard biopsy was performed. In children, tTG tends to be even more sensitive. The practical takeaway is that these blood tests are good enough to screen confidently for celiac disease, though a positive result is typically confirmed with an intestinal biopsy before starting a lifelong gluten-free diet.
One thing to watch for: these tests rely on IgA antibodies, and a small percentage of the population has IgA deficiency. In those people, the standard celiac blood panel can come back falsely negative. Your doctor may check your total IgA level alongside the celiac panel to make sure the results are interpretable.
Nutritional Markers That Point to Malabsorption
When the gut is not absorbing nutrients properly, the evidence shows up in blood work. Iron deficiency, as discussed earlier, is one of the most common signals. In celiac disease specifically, occult gastrointestinal bleeding can be detected in about half of patients and contributes to iron deficiency on top of the malabsorption itself.13PubMed. The prevalence of occult gastrointestinal bleeding in celiac sprue
Vitamin B12 is another marker clinicians check when they suspect digestive trouble. Total serum B12 is the standard first-line test, with active B12 used as a follow-up when results are borderline. If both are inconclusive, methylmalonic acid or homocysteine levels can help clarify whether a true deficiency exists, though these markers can also be elevated in non-digestive conditions.14PubMed Central. Vitamin B12 deficiency: testing and treatment Low B12 can reflect poor absorption in the stomach (as in autoimmune gastritis) or in the small intestine (as in Crohn’s disease affecting the terminal ileum).
Serum albumin rounds out the nutritional picture. Albumin is the most abundant protein in the blood, and low levels can indicate that the gut is losing protein faster than the liver can replace it, a condition called protein-losing enteropathy. All patients with this condition have low serum albumin.15Digestion. Synthesis Rates of Albumin and Fibrinogen in Patients with Protein-Losing Enteropathy and in a Patient Recovering from Protein Malnutrition The gut’s albumin clearance has to increase dramatically before serum levels drop, so by the time albumin is low, the protein loss is already substantial.16PubMed Central. Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states
Autoimmune Gastritis and Gastrin
Autoimmune gastritis is an underdiagnosed condition in which the immune system attacks the acid-producing cells of the stomach. The blood test most associated with it is anti-parietal cell antibodies (APCA), which target the proton pump enzyme in stomach lining cells. These antibodies are found in roughly 85% to 90% of patients with pernicious anemia, the severe form of autoimmune gastritis that causes B12 deficiency.17PubMed. Anti-parietal cell antibodies – diagnostic significance However, APCA are not perfectly specific. They can show up in people with other conditions, so a positive result is a screening tool rather than a definitive diagnosis.18PubMed Central. Improving the Diagnosis of Autoimmune Gastritis: From Parietal Cell Antibodies to H+/K+ ATPase Antibodies
Serum gastrin is a related test that adds context. Gastrin is the hormone that tells your stomach to make acid. When the acid-producing cells are destroyed, as in pernicious anemia, the stomach loses its acidity, and gastrin levels can soar above 1,000 pg/mL in severe cases. But elevated gastrin is not unique to autoimmune gastritis. Proton pump inhibitors (PPIs) also raise gastrin by suppressing acid, usually to a more modest range around 200 to 400 pg/mL. At the extreme end, gastrin-secreting tumors called gastrinomas can push levels above 2,000 pg/mL.19Gastroenterology Report. Hypergastrinemia Knowing a patient’s medication history is essential for interpreting a high gastrin result.
Antibody Panels for Inflammatory Bowel Disease
Beyond CRP, there are blood tests designed to help distinguish between the two main forms of IBD: Crohn’s disease and ulcerative colitis. The most established are ASCA (anti-Saccharomyces cerevisiae antibodies) and pANCA (perinuclear anti-neutrophil cytoplasmic antibodies). ASCA tends to be positive in Crohn’s disease, while pANCA is more closely associated with ulcerative colitis.20PubMed. p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn’s disease
A study of children and young adults found ASCA antibodies in 44% of Crohn’s patients, 0% of ulcerative colitis patients, and essentially no healthy controls. pANCA appeared in 70% of ulcerative colitis patients and only 18% of those with Crohn’s (mostly those whose Crohn’s affected the colon).21PubMed. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn’s disease and ulcerative colitis: diagnostic value and correlation with disease phenotype These tests are most useful in cases of “indeterminate colitis,” where endoscopy and biopsy have not clearly settled the question. They are not sensitive enough to serve as standalone diagnostic tests, but the combination adds a useful piece to the puzzle.
The BUN-to-Creatinine Ratio in GI Bleeding
When doctors suspect gastrointestinal bleeding, a basic metabolic panel can offer a surprisingly specific clue about where the bleeding is happening. Blood in the upper GI tract (stomach or duodenum) gets digested like food, and the proteins in it are broken down and absorbed, which raises blood urea nitrogen (BUN). Creatinine, by contrast, is not affected by digested blood. So a high BUN-to-creatinine ratio tips the scales toward upper rather than lower GI bleeding. A recent study found that a BUN-to-creatinine cutoff of 23.3 had about 89% sensitivity and 94% specificity for distinguishing upper from lower GI bleeding. Patients above that threshold also had higher rates of needing transfusions and endoscopic procedures.22PubMed Central. The role of BUN/creatinine ratio in determining the severity of gastrointestinal bleeding and bleeding localization
Tumor Markers for Digestive Cancers
CEA (carcinoembryonic antigen) and CA 19-9 are the tumor markers most associated with gastrointestinal cancers. They are often requested during workups for unexplained weight loss or other concerning digestive symptoms. Their limitations, though, are substantial. A large screening study found that CEA had a sensitivity of only about 8% and a positive predictive value under 4% for detecting gastrointestinal cancers in a general screening population. CA 19-9 performed similarly poorly.23Scientific Reports. Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening
Where these markers do perform well is in specific clinical scenarios. For pancreatic cancer, combining CA 19-9 and CA 125 yielded a sensitivity of 97%, and the combination was highly effective at distinguishing pancreatic cancer from chronic pancreatitis (only 4% false positive in pancreatitis).24Gut. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system So these markers are poor for general cancer screening but valuable when a specific cancer is already suspected or when monitoring a known cancer’s response to treatment.
Bile Acid Malabsorption Testing
Chronic watery diarrhea that does not respond to standard treatments can sometimes be caused by bile acid malabsorption. The gold standard diagnostic test is 75SeHCAT, a nuclear medicine scan, but blood-based alternatives exist. Serum C4 (7-alpha-hydroxy-4-cholesten-3-one) is a blood test that reflects how fast the liver is making new bile acids to replace the ones being lost. A systematic review found that serum C4 had about 85% sensitivity and 71% specificity for bile acid malabsorption. Another blood marker, fibroblast growth factor 19 (FGF19), performed less well, with roughly 64% sensitivity and 72% specificity.25PubMed Central. Methods for diagnosing bile acid malabsorption: a systematic review These blood tests are not perfect substitutes for 75SeHCAT, but they are more widely available and do not require nuclear medicine facilities.
The IgG Food Sensitivity Test Controversy
Commercial labs now market blood panels that measure IgG antibodies to dozens of foods, claiming to identify “food sensitivities” responsible for bloating, diarrhea, and other digestive symptoms. The science behind these tests is shaky. One study did find that patients with irritable bowel syndrome had higher IgG antibody levels to certain foods compared to healthy controls, but there was no correlation between the antibody levels and symptom severity.26PubMed. Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia IgG antibodies to food may simply reflect exposure to those foods rather than any meaningful intolerance. Most professional allergy and gastroenterology organizations advise against using IgG food panels for diagnostic purposes, and elimination diets guided by these results can lead to unnecessarily restricted eating.
Blood Tests for Monitoring Existing Digestive Conditions
Once a digestive disease is diagnosed, blood testing takes on a different role: tracking treatment effectiveness and preventing complications. For patients with inflammatory bowel disease on biologic drugs like infliximab or adalimumab, therapeutic drug monitoring (TDM) measures the drug’s blood level and checks for antibodies that the immune system may be producing against the medication. An expert consensus statement recommends reactive TDM for all biologics when patients stop responding, and proactive TDM (routine monitoring even when things seem stable) for anti-TNF therapies specifically.27PubMed Central. A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease Proactive monitoring helps prevent the loss of response that can happen when drug levels drift too low or antibodies build up gradually.28PubMed Central. Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
Pharmacogenomic testing is a newer layer. Some IBD patients are treated with thiopurine drugs like azathioprine, which can cause dangerous drops in white blood cells in people who carry certain genetic variants. Testing for TPMT and NUDT15 gene variants before starting the drug helps identify who is at risk. A prospective study found that patients with NUDT15 polymorphisms had roughly 3.6 times the odds of developing low white cell counts on thiopurine therapy.29BMC Gastroenterol. TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India This kind of pre-treatment blood test does not diagnose a digestive disease, but it shapes how safely that disease can be treated.
Intestinal Permeability Markers
You may have encountered the phrase “leaky gut” in wellness circles. The scientific version of this concept involves measuring blood markers that increase when the intestinal barrier is compromised, allowing bacterial components to cross into the bloodstream. Researchers have explored these gut permeability markers in various settings, including depression and suicidal behavior, looking at whether bacterial translocation across the intestinal wall contributes to systemic inflammation.30PubMed Central. Leaky gut biomarkers in depression and suicidal behavior While the concept is real and measurable in research, intestinal permeability tests are not yet part of routine clinical practice for diagnosing digestive diseases. They remain largely a research tool, and the commercial “leaky gut” tests marketed directly to consumers have not been validated for guiding treatment decisions.